Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 699.00
+11.00 (1.60%)
At close: Aug 11, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
| Medicine | 60.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Growth | -4.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Steel | 46.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Steel Growth | 0.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hardfacing | 32.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hardfacing Growth | 8.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| NUKON | 8.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| NUKON Growth | 120.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biosimilar | 551.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biosimilar Growth | -85.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Game | 39.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Game Growth | -88.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -45.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Construction - NUKON | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Construction - NUKON Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glycholine soft capsule | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glycholine soft capsule Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandised - Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandised - Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Foam Glass | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Foam Glass Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glutanex Injection | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Manufactured - Glutanex Injection Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service - Dragon Raja Origin | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
| South Korea | 139.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 6.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 10.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -45.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|